Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
20.84%
operating margin TTM
20.29%
revenue TTM
496.73 Million
revenue per share TTM
4.71$
valuation ratios | |
|---|---|
| pe ratio | 41.52 |
| peg ratio | -56.47 |
| price to book ratio | 8.60 |
| price to sales ratio | 8.84 |
| enterprise value multiple | 44.29 |
| price fair value | 8.60 |
profitability ratios | |
|---|---|
| gross profit margin | 98.39% |
| operating profit margin | 20.29% |
| pretax profit margin | 23.92% |
| net profit margin | 20.84% |
| return on assets | 16.74% |
| return on equity | 22.85% |
| return on capital employed | 19.57% |
liquidity ratio | |
|---|---|
| current ratio | 3.35 |
| quick ratio | 3.26 |
| cash ratio | 0.91 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 416.32 |
| operating cycle | 445.50 |
| days of payables outstanding | 515.74 |
| cash conversion cycle | -70.23 |
| receivables turnover | 12.51 |
| payables turnover | 0.71 |
| inventory turnover | 0.88 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 28.56 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.90 |
| cash per share | 3.71 |
| operating cash flow per share | 1.92 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 28.56 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 91.19 |
Frequently Asked Questions
When was the last time Corcept Therapeutics Incorporated (NASDAQ:CORT) reported earnings?
Corcept Therapeutics Incorporated (CORT) published its most recent earnings results on 30-10-2024.
What is Corcept Therapeutics Incorporated's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Corcept Therapeutics Incorporated (NASDAQ:CORT)'s trailing twelve months ROE is 22.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Corcept Therapeutics Incorporated (CORT) currently has a ROA of 16.74%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CORT's net profit margin stand at?
CORT reported a profit margin of 20.84% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CORT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.35 in the most recent quarter. The quick ratio stood at 3.26, with a Debt/Eq ratio of 0.01.